Folinic Acid Calcium Salt Pentahydrate
CAS No. 6035-45-6
Folinic Acid Calcium Salt Pentahydrate ( —— )
Catalog No. M15258 CAS No. 6035-45-6
Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 28 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 74 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFolinic Acid Calcium Salt Pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFolinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.
-
DescriptionFolinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.(In Vitro):MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .(In Vivo):Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice).
-
In VitroMTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .
-
In VivoFolinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice). Animal Model:24 Balb/c young growing male mice aged 3 weeks (11.88 ± 0.25 g) Dosage:7.0 mg/kg Administration:Intraperitoneal injection; every second day; for 3 weeks Result:Following methotrexate (MTX) administration appears to reverse this growth inhibition.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFolate Analogue
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number6035-45-6
-
Formula Weight601.58
-
Molecular FormulaC20H21CaN7O7·5H2O
-
Purity>98% (HPLC)
-
SolubilityWater: 40 mg/mL warmed (66.49 mM)
-
SMILESNC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2C=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Van der Wilt CL, et al. Y Res, 1992, 52(18), 4922-4928.
molnova catalog
related products
-
β-Endorphin (1-26), ...
β-Endorphin (1-26), human
-
RO5166017
RO5166017 is an orally active, potent and selective trace amine-associated receptor 1 (TAAR1) agonist for the study of conditioned taste aversion frontal nerve disorders.
-
alphaSYN-IN-NAB2
alphaSYN-IN-NAB2, a neuron-protective agent, is a protein encoded by the NAB2 gene. NAB2 effectively and selectively protects a variety of cells from alpha-SYN toxicity.
Cart
sales@molnova.com